FIELD: medicine.
SUBSTANCE: invention refers to medicine, particularly to pharmacology, and concerns development of the new antiaggregant. For this purpose Tropoxin (hydrochloride 3-(3,4,5-trioxybenzoyl-oxyimino)-8-methyl-8-azabicyclo[3,2,1]octane) commonly used as antimigraine agent.
EFFECT: tropoxin is characterised with antiaggregatory activity exceeding the activity of Trental commonly used in clinical practice.
8 ex
| Title | Year | Author | Number |
|---|---|---|---|
| PHARMACEUTICAL COMPOSITION WITH ANTIMIGRAINE ACTION (VERSIONS) | 2008 |
|
RU2424803C2 |
| AGENTS WITH HEMORHEOLOGICAL, ANTIAGGREGANT AND ANTITROMBOGENIC ACTIVITY | 2007 |
|
RU2347561C2 |
| METHOD FOR PATIENT-SPECIFIC SELECTION OF ANTIPLATELET DRUGS FOR PATIENTS IN NEED THEREOF | 2012 |
|
RU2499261C1 |
| METHOD OF REDUCING AGGREGATION ACTIVITY OF PLATELETS in vitro | 2009 |
|
RU2410104C1 |
| 3-METHYL-8-PIPERAZINE-7-(THIETHANYL-3)-1-ETHYLXANTHINE HYDROCHLORIDE, EXHIBITING ANTIAGGREGANT AND DISAGGREGATION ACTIVITY | 2009 |
|
RU2404181C1 |
| METHOD OF DETERMINING PLATELET RESISTANCE TO ACETYLSALICYLIC ACID | 2013 |
|
RU2538219C2 |
| REMEDY HAVING ANTIAGGREGANT ACTIVITY, ACTIVITY DECREASING BLOOD HYPERVISCOSITY AND ANTITHROMBOGENIC ACTIVITY | 2008 |
|
RU2368376C1 |
| METHOD FOR DIFFERENTIAL DIAGNOSTICS OF HEPATIC DAMAGE ETIOLOGY IN PATIENTS WITH CIRRHOSIS | 2010 |
|
RU2442981C1 |
| 2-CYCLOALKYLAMINO-5-THIENYL-1,3,4-THIADIAZINES, HYDROBROMIDES, WITH ANTIAGGREGANT ACTIVITY | 2008 |
|
RU2379306C1 |
| AGENT POSSESSING HEMORGHEOLOGICAL AND ANTIPLATELET ACTIVITY | 2007 |
|
RU2342944C1 |
